ClinicalTrials.Veeva

Menu

Effect of Progesterone Therapy on Traumatic Subarachinoid Haemorrhage on Clinical Outcome and Resistive Vasculer Indices of Middle Cerebral Artery Transcranial Doppler

M

Minia University

Status and phase

Unknown
Early Phase 1

Conditions

Traumatic Brain Injury

Treatments

Drug: Progesterone

Study type

Interventional

Funder types

Other

Identifiers

NCT04426487
625/4-2020

Details and patient eligibility

About

Traumatic subarachinoid hemorrhage is associated with serious complications related to mortality . Delayed neuronal ischemia and rebleeding are most common and serious. Progesterone can delay both .

Full description

Progesterone is an neurosteroid that can help integrity of blood brain barrier . Traumatic subarachinoid hemorrhage disrupts this blood brain barrier facilitating post traumatic vasospasm and neuronal ischemia. Transcranial doppler can detect cerebral vasoconstriction through resistive vasculer indices

Enrollment

200 estimated patients

Sex

All

Ages

20 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Traumatic subarachinoid hemorrhage

Exclusion criteria

  • History of malignency

    • History of cerebrovasculer stroke
    • Morbid obese

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

200 participants in 2 patient groups, including a placebo group

Control
Placebo Comparator group
Description:
Receiving conventional management for traumatic subarachinoid hemorrhage
Treatment:
Drug: Progesterone
progesterone group
Active Comparator group
Description:
Intramusculer progesterone therapy before and after craniotomy
Treatment:
Drug: Progesterone

Trial contacts and locations

1

Loading...

Central trial contact

Mina Raouf, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems